Gene Symbol | Gene ID | Gene Info |
---|---|---|
SCRT1
|
ENSG00000170616.9 | scratch family transcriptional repressor 1 |
SCRT2
|
ENSG00000215397.3 | scratch family transcriptional repressor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_145555628_145555779 | SCRT1 | 4240 | 0.084133 | 0.55 | 1.3e-01 | Click! |
chr8_145558373_145558524 | SCRT1 | 1495 | 0.180572 | -0.49 | 1.8e-01 | Click! |
chr8_145555253_145555567 | SCRT1 | 4533 | 0.082086 | 0.38 | 3.2e-01 | Click! |
chr8_145559016_145559167 | SCRT1 | 852 | 0.340036 | 0.36 | 3.5e-01 | Click! |
chr8_145561150_145561433 | SCRT1 | 1348 | 0.201225 | 0.30 | 4.3e-01 | Click! |
chr20_684137_684288 | SCRT2 | 27389 | 0.145446 | -0.63 | 7.1e-02 | Click! |
chr20_680713_680864 | SCRT2 | 23965 | 0.150743 | -0.48 | 1.9e-01 | Click! |
chr20_682209_682360 | SCRT2 | 25461 | 0.148482 | -0.32 | 4.1e-01 | Click! |
chr20_656821_656972 | SCRT2 | 73 | 0.866781 | -0.22 | 5.8e-01 | Click! |
chr20_657228_657379 | SCRT2 | 480 | 0.629237 | 0.15 | 7.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_2950342_2950493 | 0.89 |
RP11-737O24.2 |
|
2078 |
0.26 |
chr1_111436407_111436686 | 0.84 |
CD53 |
CD53 molecule |
20770 |
0.16 |
chr2_34257_34408 | 0.77 |
FAM110C |
family with sequence similarity 110, member C |
12053 |
0.3 |
chr8_10905444_10905762 | 0.74 |
ENSG00000207600 |
. |
12791 |
0.17 |
chr13_28002327_28002478 | 0.74 |
GTF3A |
general transcription factor IIIA |
1693 |
0.33 |
chr5_169762940_169763200 | 0.72 |
KCNIP1 |
Kv channel interacting protein 1 |
17421 |
0.18 |
chr20_3795874_3796116 | 0.70 |
AP5S1 |
adaptor-related protein complex 5, sigma 1 subunit |
5183 |
0.13 |
chr11_128495747_128495961 | 0.68 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
38401 |
0.15 |
chr2_42523029_42523463 | 0.66 |
EML4 |
echinoderm microtubule associated protein like 4 |
5147 |
0.28 |
chr7_99820202_99820353 | 0.66 |
ENSG00000222482 |
. |
2534 |
0.13 |
chr3_71778250_71778401 | 0.64 |
EIF4E3 |
eukaryotic translation initiation factor 4E family member 3 |
23 |
0.98 |
chr9_7977098_7977328 | 0.64 |
TMEM261 |
transmembrane protein 261 |
177146 |
0.04 |
chr9_92082755_92083098 | 0.63 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
11879 |
0.23 |
chr11_60833627_60833778 | 0.62 |
CD5 |
CD5 molecule |
36165 |
0.12 |
chr11_128195267_128195435 | 0.62 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
179938 |
0.03 |
chrX_65224779_65225318 | 0.61 |
RP6-159A1.3 |
|
5455 |
0.23 |
chr12_45242239_45242528 | 0.60 |
NELL2 |
NEL-like 2 (chicken) |
26868 |
0.21 |
chr16_3266168_3266379 | 0.60 |
OR1F1 |
olfactory receptor, family 1, subfamily F, member 1 |
12026 |
0.09 |
chrX_13015430_13015581 | 0.59 |
TMSB4X |
thymosin beta 4, X-linked |
21728 |
0.2 |
chr17_66341426_66341824 | 0.59 |
ARSG |
arylsulfatase G |
53966 |
0.11 |
chr1_158218083_158218416 | 0.58 |
CD1A |
CD1a molecule |
5678 |
0.21 |
chr5_131337366_131337561 | 0.58 |
ACSL6 |
acyl-CoA synthetase long-chain family member 6 |
111 |
0.94 |
chr19_43943775_43943926 | 0.58 |
TEX101 |
testis expressed 101 |
24786 |
0.12 |
chr16_68107852_68108775 | 0.57 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
10934 |
0.1 |
chr7_21476358_21476516 | 0.57 |
SP4 |
Sp4 transcription factor |
8776 |
0.19 |
chr2_69000872_69001023 | 0.55 |
ARHGAP25 |
Rho GTPase activating protein 25 |
986 |
0.63 |
chr8_101394406_101394557 | 0.55 |
ENSG00000265599 |
. |
510 |
0.82 |
chr6_159484612_159484848 | 0.55 |
TAGAP |
T-cell activation RhoGTPase activating protein |
18546 |
0.19 |
chr19_16172698_16172849 | 0.54 |
TPM4 |
tropomyosin 4 |
5058 |
0.2 |
chr16_67839951_67840102 | 0.53 |
RANBP10 |
RAN binding protein 10 |
434 |
0.53 |
chr19_41811104_41811255 | 0.53 |
CCDC97 |
coiled-coil domain containing 97 |
4915 |
0.12 |
chr15_83419735_83419886 | 0.53 |
RP11-752G15.6 |
|
474 |
0.7 |
chr2_173300165_173300317 | 0.52 |
AC078883.4 |
|
6910 |
0.19 |
chr16_1806858_1807155 | 0.52 |
LA16c-361A3.3 |
|
4743 |
0.08 |
chr17_61631526_61631679 | 0.52 |
DCAF7 |
DDB1 and CUL4 associated factor 7 |
3741 |
0.16 |
chr2_48554305_48554459 | 0.52 |
FOXN2 |
forkhead box N2 |
12533 |
0.21 |
chr15_66686411_66686632 | 0.52 |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
7366 |
0.13 |
chr17_15496543_15496749 | 0.52 |
CDRT1 |
CMT1A duplicated region transcript 1 |
76 |
0.96 |
chr3_51710255_51710406 | 0.52 |
TEX264 |
testis expressed 264 |
4419 |
0.18 |
chr10_124302381_124302577 | 0.51 |
DMBT1 |
deleted in malignant brain tumors 1 |
17702 |
0.2 |
chr16_57300928_57301079 | 0.50 |
PLLP |
plasmolipin |
3720 |
0.16 |
chr3_56705961_56706112 | 0.50 |
FAM208A |
family with sequence similarity 208, member A |
7677 |
0.29 |
chrX_21458755_21458906 | 0.49 |
CNKSR2 |
connector enhancer of kinase suppressor of Ras 2 |
65850 |
0.14 |
chr7_44663921_44664244 | 0.48 |
OGDH |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
21 |
0.98 |
chr7_3134972_3135255 | 0.48 |
CARD11 |
caspase recruitment domain family, member 11 |
51534 |
0.14 |
chr1_32716017_32716330 | 0.48 |
LCK |
lymphocyte-specific protein tyrosine kinase |
667 |
0.47 |
chr10_22924597_22924817 | 0.48 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
44065 |
0.19 |
chr1_175177928_175178377 | 0.48 |
KIAA0040 |
KIAA0040 |
16073 |
0.25 |
chr1_31220295_31220566 | 0.47 |
ENSG00000264773 |
. |
8351 |
0.16 |
chr16_50718032_50718183 | 0.47 |
SNX20 |
sorting nexin 20 |
2843 |
0.17 |
chr13_41576792_41576957 | 0.47 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
16576 |
0.19 |
chr6_35232562_35232713 | 0.47 |
ZNF76 |
zinc finger protein 76 |
5086 |
0.21 |
chr3_197709745_197709896 | 0.47 |
ENSG00000201622 |
. |
11652 |
0.14 |
chr17_30819830_30820272 | 0.46 |
RP11-466A19.1 |
|
2503 |
0.17 |
chr10_88273543_88273741 | 0.46 |
WAPAL |
wings apart-like homolog (Drosophila) |
7930 |
0.19 |
chr15_61138512_61138663 | 0.46 |
RP11-554D20.1 |
|
81648 |
0.1 |
chr21_36318885_36319060 | 0.46 |
RUNX1 |
runt-related transcription factor 1 |
56885 |
0.17 |
chr4_139997269_139997476 | 0.46 |
ELF2 |
E74-like factor 2 (ets domain transcription factor) |
7972 |
0.15 |
chr19_16478953_16479699 | 0.45 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
6562 |
0.16 |
chr7_135678278_135678429 | 0.45 |
MTPN |
myotrophin |
16252 |
0.18 |
chr1_226886506_226886745 | 0.45 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
23857 |
0.17 |
chr6_24866983_24867134 | 0.45 |
FAM65B |
family with sequence similarity 65, member B |
10483 |
0.19 |
chr17_36917697_36917848 | 0.45 |
ENSG00000252278 |
. |
6119 |
0.08 |
chr20_3104193_3104344 | 0.45 |
UBOX5-AS1 |
UBOX5 antisense RNA 1 |
12985 |
0.11 |
chr3_66546617_66547002 | 0.44 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
4547 |
0.35 |
chr15_44970403_44970608 | 0.44 |
PATL2 |
protein associated with topoisomerase II homolog 2 (yeast) |
1419 |
0.34 |
chr8_81953365_81953516 | 0.43 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
70863 |
0.12 |
chr10_112686766_112686917 | 0.43 |
SHOC2 |
soc-2 suppressor of clear homolog (C. elegans) |
7536 |
0.14 |
chr11_44733333_44733484 | 0.43 |
TSPAN18 |
tetraspanin 18 |
14607 |
0.26 |
chr3_196285550_196285792 | 0.43 |
WDR53 |
WD repeat domain 53 |
8510 |
0.14 |
chr11_117875887_117876045 | 0.43 |
IL10RA |
interleukin 10 receptor, alpha |
18857 |
0.16 |
chr6_90017847_90017998 | 0.43 |
GABRR2 |
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
7045 |
0.22 |
chr10_13150983_13151182 | 0.43 |
OPTN |
optineurin |
7186 |
0.2 |
chr13_52029149_52029538 | 0.42 |
INTS6 |
integrator complex subunit 6 |
943 |
0.38 |
chr11_118098933_118099084 | 0.42 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
3199 |
0.19 |
chr17_4080390_4080680 | 0.42 |
ENSG00000251812 |
. |
9086 |
0.12 |
chr1_209931882_209932204 | 0.42 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
200 |
0.92 |
chr17_62172889_62173162 | 0.42 |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
34460 |
0.13 |
chr17_38738642_38738946 | 0.42 |
CCR7 |
chemokine (C-C motif) receptor 7 |
17070 |
0.15 |
chr3_101239038_101239189 | 0.42 |
SENP7 |
SUMO1/sentrin specific peptidase 7 |
7028 |
0.16 |
chr12_9921460_9921827 | 0.41 |
CD69 |
CD69 molecule |
8146 |
0.16 |
chr20_58873731_58873882 | 0.41 |
ENSG00000207802 |
. |
9726 |
0.31 |
chr12_107764979_107765261 | 0.41 |
ENSG00000200897 |
. |
3404 |
0.32 |
chr8_128994485_128994662 | 0.41 |
ENSG00000207110 |
. |
16804 |
0.16 |
chr2_12872493_12872644 | 0.41 |
ENSG00000264370 |
. |
4925 |
0.28 |
chrX_46405353_46405504 | 0.41 |
ZNF674 |
zinc finger protein 674 |
552 |
0.79 |
chrX_46476947_46477359 | 0.41 |
CHST7 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
43934 |
0.16 |
chr7_44511311_44511462 | 0.41 |
NUDCD3 |
NudC domain containing 3 |
19093 |
0.17 |
chr13_46698042_46698195 | 0.41 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
18897 |
0.15 |
chr6_24968603_24968754 | 0.41 |
FAM65B |
family with sequence similarity 65, member B |
32490 |
0.17 |
chr7_8154178_8154625 | 0.41 |
AC006042.6 |
|
746 |
0.72 |
chr13_30950302_30950776 | 0.41 |
KATNAL1 |
katanin p60 subunit A-like 1 |
68918 |
0.11 |
chr3_12505287_12505438 | 0.40 |
TSEN2 |
TSEN2 tRNA splicing endonuclease subunit |
20569 |
0.16 |
chr5_118637816_118638007 | 0.40 |
ENSG00000243333 |
. |
4415 |
0.23 |
chr18_21621225_21621531 | 0.40 |
TTC39C |
tetratricopeptide repeat domain 39C |
24780 |
0.14 |
chr12_56531615_56531824 | 0.40 |
RP11-603J24.5 |
|
8316 |
0.06 |
chr2_231612077_231612228 | 0.39 |
ENSG00000201044 |
. |
4704 |
0.25 |
chr16_75497628_75497805 | 0.39 |
TMEM170A |
transmembrane protein 170A |
598 |
0.42 |
chr3_32337882_32338356 | 0.39 |
ENSG00000207857 |
. |
36899 |
0.15 |
chr16_20952479_20952845 | 0.39 |
LYRM1 |
LYR motif containing 1 |
40236 |
0.13 |
chr6_24986522_24986707 | 0.39 |
ENSG00000244618 |
. |
44896 |
0.13 |
chr1_24239728_24239943 | 0.39 |
CNR2 |
cannabinoid receptor 2 (macrophage) |
17 |
0.96 |
chr2_143940127_143940582 | 0.39 |
RP11-190J23.1 |
|
10613 |
0.27 |
chrX_17828294_17828445 | 0.39 |
RAI2 |
retinoic acid induced 2 |
27481 |
0.23 |
chr8_134054811_134054962 | 0.39 |
SLA |
Src-like-adaptor |
17717 |
0.22 |
chr15_31488088_31488239 | 0.38 |
TRPM1 |
transient receptor potential cation channel, subfamily M, member 1 |
34687 |
0.2 |
chr17_56411933_56412610 | 0.38 |
ENSG00000264399 |
. |
1112 |
0.31 |
chr19_19563261_19563412 | 0.38 |
GATAD2A |
GATA zinc finger domain containing 2A |
4585 |
0.15 |
chr18_77887547_77887698 | 0.38 |
ADNP2 |
ADNP homeobox 2 |
12123 |
0.18 |
chr3_127308421_127308689 | 0.38 |
TPRA1 |
transmembrane protein, adipocyte asscociated 1 |
987 |
0.55 |
chr16_89907669_89907888 | 0.38 |
SPIRE2 |
spire-type actin nucleation factor 2 |
12823 |
0.13 |
chr2_87820812_87821026 | 0.38 |
RP11-1399P15.1 |
|
43366 |
0.19 |
chr21_15922850_15923077 | 0.38 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
4299 |
0.28 |
chr3_121375406_121375557 | 0.38 |
ENSG00000222057 |
. |
1030 |
0.43 |
chr22_25472244_25472403 | 0.38 |
KIAA1671 |
KIAA1671 |
6387 |
0.24 |
chr16_18494696_18494857 | 0.38 |
PKD1P5 |
polycystic kidney disease 1 (autosomal dominant) pseudogene 5 |
1021 |
0.3 |
chr12_27103540_27103691 | 0.38 |
FGFR1OP2 |
FGFR1 oncogene partner 2 |
12182 |
0.14 |
chr12_3856035_3856186 | 0.38 |
EFCAB4B |
EF-hand calcium binding domain 4B |
6153 |
0.25 |
chr3_46965322_46965583 | 0.38 |
PTH1R |
parathyroid hormone 1 receptor |
21363 |
0.13 |
chr11_102319516_102319792 | 0.37 |
TMEM123 |
transmembrane protein 123 |
529 |
0.74 |
chr21_32549274_32549453 | 0.37 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
46824 |
0.18 |
chr19_7451520_7451875 | 0.37 |
CTD-2207O23.3 |
Rho guanine nucleotide exchange factor 18 |
5847 |
0.14 |
chr6_53143430_53143680 | 0.37 |
ENSG00000264056 |
. |
1764 |
0.38 |
chr21_19176751_19176973 | 0.37 |
AL109761.5 |
|
4400 |
0.25 |
chrX_15815885_15816036 | 0.37 |
ZRSR2 |
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 |
7365 |
0.21 |
chr5_55773462_55773845 | 0.37 |
CTC-236F12.4 |
Uncharacterized protein |
3943 |
0.25 |
chr1_27958988_27959229 | 0.37 |
FGR |
feline Gardner-Rasheed sarcoma viral oncogene homolog |
2619 |
0.2 |
chr20_3389476_3389665 | 0.37 |
C20orf194 |
chromosome 20 open reading frame 194 |
1298 |
0.37 |
chr13_100630372_100630523 | 0.37 |
ZIC2 |
Zic family member 2 |
3579 |
0.22 |
chr5_131418625_131418776 | 0.36 |
ENSG00000253067 |
. |
2941 |
0.21 |
chr2_228679175_228679326 | 0.36 |
CCL20 |
chemokine (C-C motif) ligand 20 |
680 |
0.73 |
chr1_207088313_207088465 | 0.36 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
6823 |
0.15 |
chr15_44968583_44968823 | 0.36 |
PATL2 |
protein associated with topoisomerase II homolog 2 (yeast) |
45 |
0.97 |
chr12_106978251_106978549 | 0.36 |
RFX4 |
regulatory factor X, 4 (influences HLA class II expression) |
977 |
0.67 |
chr1_27159233_27159384 | 0.36 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
797 |
0.49 |
chr1_24811001_24811158 | 0.36 |
RCAN3 |
RCAN family member 3 |
18308 |
0.16 |
chr2_162810786_162811012 | 0.36 |
ENSG00000253046 |
. |
35607 |
0.2 |
chr17_75843070_75843221 | 0.36 |
FLJ45079 |
|
35514 |
0.19 |
chr10_8480330_8480960 | 0.36 |
ENSG00000212505 |
. |
218149 |
0.02 |
chr6_149453675_149453979 | 0.36 |
ENSG00000263481 |
. |
44103 |
0.16 |
chr17_28689611_28689964 | 0.35 |
ENSG00000201255 |
. |
2306 |
0.21 |
chr10_14045463_14045668 | 0.35 |
FRMD4A |
FERM domain containing 4A |
4967 |
0.24 |
chr12_6573393_6573619 | 0.35 |
VAMP1 |
vesicle-associated membrane protein 1 (synaptobrevin 1) |
6305 |
0.09 |
chr16_9373482_9373633 | 0.35 |
ENSG00000264694 |
. |
34204 |
0.18 |
chr14_52381406_52381557 | 0.35 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
1651 |
0.33 |
chr2_173330251_173330570 | 0.35 |
AC078883.3 |
|
330 |
0.88 |
chr7_122526708_122526859 | 0.35 |
CADPS2 |
Ca++-dependent secretion activator 2 |
30 |
0.99 |
chr12_29543394_29543588 | 0.35 |
OVCH1-AS1 |
OVCH1 antisense RNA 1 |
820 |
0.62 |
chr22_19861779_19861930 | 0.35 |
GNB1L |
guanine nucleotide binding protein (G protein), beta polypeptide 1-like |
19392 |
0.14 |
chr12_7056002_7056374 | 0.34 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
415 |
0.56 |
chr1_226891897_226892201 | 0.34 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
29281 |
0.16 |
chr3_187676960_187677188 | 0.34 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
193998 |
0.03 |
chrX_71524778_71525062 | 0.34 |
CITED1 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
495 |
0.77 |
chr15_42263441_42263654 | 0.34 |
EHD4 |
EH-domain containing 4 |
1229 |
0.3 |
chr12_120445548_120445820 | 0.34 |
CCDC64 |
coiled-coil domain containing 64 |
18011 |
0.19 |
chr3_71472115_71472375 | 0.34 |
FOXP1 |
forkhead box P1 |
118334 |
0.06 |
chr17_53343826_53343977 | 0.34 |
HLF |
hepatic leukemia factor |
318 |
0.92 |
chr17_72727128_72727410 | 0.33 |
RAB37 |
RAB37, member RAS oncogene family |
5468 |
0.11 |
chr6_12071674_12071825 | 0.33 |
HIVEP1 |
human immunodeficiency virus type I enhancer binding protein 1 |
54230 |
0.16 |
chr3_119281402_119281624 | 0.33 |
CD80 |
CD80 molecule |
3064 |
0.19 |
chrX_56395778_56395937 | 0.33 |
KLF8 |
Kruppel-like factor 8 |
136377 |
0.05 |
chr19_23870785_23870936 | 0.33 |
ZNF675 |
zinc finger protein 675 |
838 |
0.7 |
chr8_27189983_27190134 | 0.33 |
PTK2B |
protein tyrosine kinase 2 beta |
5718 |
0.23 |
chr15_44960524_44961220 | 0.33 |
PATL2 |
protein associated with topoisomerase II homolog 2 (yeast) |
189 |
0.93 |
chr10_61641353_61641504 | 0.33 |
CCDC6 |
coiled-coil domain containing 6 |
24986 |
0.23 |
chr3_16880178_16880359 | 0.33 |
PLCL2 |
phospholipase C-like 2 |
46184 |
0.18 |
chr6_52930879_52931030 | 0.33 |
FBXO9 |
F-box protein 9 |
119 |
0.95 |
chr8_21436069_21436236 | 0.33 |
ENSG00000266630 |
. |
28643 |
0.23 |
chr7_99760518_99760936 | 0.33 |
GAL3ST4 |
galactose-3-O-sulfotransferase 4 |
4126 |
0.07 |
chr2_204596754_204596977 | 0.33 |
CD28 |
CD28 molecule |
25449 |
0.18 |
chr10_116302372_116302551 | 0.33 |
ABLIM1 |
actin binding LIM protein 1 |
15771 |
0.26 |
chr2_97504509_97504660 | 0.33 |
ANKRD23 |
ankyrin repeat domain 23 |
5158 |
0.14 |
chr16_15006337_15006488 | 0.33 |
RP11-958N24.1 |
|
1004 |
0.3 |
chr4_102203524_102203800 | 0.33 |
ENSG00000221265 |
. |
47909 |
0.15 |
chr10_100204321_100204662 | 0.32 |
HPS1 |
Hermansky-Pudlak syndrome 1 |
2176 |
0.3 |
chr16_16404977_16405128 | 0.32 |
ENSG00000265373 |
. |
1320 |
0.26 |
chr7_44472291_44472456 | 0.32 |
NUDCD3 |
NudC domain containing 3 |
58106 |
0.11 |
chr3_18386155_18386306 | 0.32 |
RP11-158G18.1 |
|
64897 |
0.13 |
chr5_50101749_50101900 | 0.32 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
138433 |
0.05 |
chr5_175095190_175095426 | 0.32 |
HRH2 |
histamine receptor H2 |
10275 |
0.21 |
chr9_134563645_134563796 | 0.32 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
21509 |
0.2 |
chr1_246888241_246888408 | 0.32 |
SCCPDH |
saccharopine dehydrogenase (putative) |
975 |
0.57 |
chr15_64005518_64005736 | 0.32 |
HERC1 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 |
35442 |
0.16 |
chr15_40067124_40067275 | 0.32 |
RP11-37C7.3 |
|
7573 |
0.18 |
chr6_149650450_149650657 | 0.32 |
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
8365 |
0.21 |
chr11_63605215_63605472 | 0.32 |
MARK2 |
MAP/microtubule affinity-regulating kinase 2 |
1057 |
0.45 |
chr13_99953455_99953623 | 0.32 |
GPR183 |
G protein-coupled receptor 183 |
6120 |
0.21 |
chr2_106380554_106380705 | 0.32 |
NCK2 |
NCK adaptor protein 2 |
18441 |
0.27 |
chr9_32551546_32551790 | 0.31 |
TOPORS-AS1 |
TOPORS antisense RNA 1 |
103 |
0.92 |
chr5_39151804_39152024 | 0.31 |
AC008964.1 |
|
46556 |
0.15 |
chr9_117133884_117134096 | 0.31 |
AKNA |
AT-hook transcription factor |
5254 |
0.22 |
chr6_52172957_52173173 | 0.31 |
MCM3 |
minichromosome maintenance complex component 3 |
23430 |
0.19 |
chr10_46019955_46020106 | 0.31 |
MARCH8 |
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase |
10789 |
0.25 |
chr13_41550140_41550291 | 0.31 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
6203 |
0.21 |
chr15_78330921_78331370 | 0.31 |
ENSG00000221476 |
. |
272 |
0.88 |
chr12_51712923_51713404 | 0.31 |
BIN2 |
bridging integrator 2 |
4736 |
0.18 |
chr1_89732076_89732227 | 0.30 |
GBP5 |
guanylate binding protein 5 |
4395 |
0.21 |
chr16_2184766_2184973 | 0.30 |
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
1030 |
0.18 |
chr2_197084731_197084906 | 0.30 |
ENSG00000239161 |
. |
4772 |
0.22 |
chr2_144015142_144015469 | 0.30 |
RP11-190J23.1 |
|
85564 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.2 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.3 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.3 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.0 | GO:0046100 | purine nucleotide salvage(GO:0032261) hypoxanthine metabolic process(GO:0046100) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:0002864 | hypersensitivity(GO:0002524) regulation of acute inflammatory response to antigenic stimulus(GO:0002864) regulation of hypersensitivity(GO:0002883) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0032634 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.3 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.0 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.0 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.2 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.1 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.2 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.0 | 0.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:0051023 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.2 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.0 | 0.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.0 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0061054 | dermatome development(GO:0061054) |
0.0 | 0.0 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.0 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.0 | 0.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.0 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.5 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.2 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.1 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.2 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.0 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.0 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.0 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.0 | 0.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |